PMID- 36928751
OWN - NLM
STAT- MEDLINE
DCOM- 20230728
LR  - 20230728
IS  - 1863-2491 (Electronic)
IS  - 1863-2483 (Linking)
VI  - 17
IP  - 4
DP  - 2023 Aug
TI  - Operative and oncological outcomes of salvage robotic radical and partial 
      nephrectomy: a multicenter experience.
PG  - 1579-1585
LID - 10.1007/s11701-023-01538-6 [doi]
AB  - We aim to describe the perioperative and oncological outcomes for salvage robotic 
      partial nephrectomy (sRPN) and salvage robotic radical nephrectomy (sRRN). Using 
      a prospectively maintained multi-institutional database, we compared baseline 
      clinical characteristics and perioperative and postoperative outcomes, including 
      pathological stage, tumor histology, operative time, ischemia time, estimated 
      blood loss (EBL), length of stay (LOS), postoperative complication rate, 
      recurrence rate, and mortality. We identified a total of 58 patients who had 
      undergone robotic salvage surgery for a recurrent renal mass, of which 22 (38%) 
      had sRRN and 36 (62%) had sRPN. Ischemia time for sRPN was 14 min. The median EBL 
      was 100 mL in both groups (p = 0.581). One intraoperative complication occurred 
      during sRRN, while three occurred during sRPN cases (p = 1.000). The median LOS 
      was 2 days for sRRN and 1 day for sRPN (p = 0.039). Postoperatively, one major 
      complication occurred after sRRN and two after sRPN (p = 1.000). The recurrence 
      reported after sRRN was 5% and 3% after sRPN. Among the patients who underwent 
      sRRN, the two most prevalent stages were pT1a (27%) and pT3a (27%). Similarly, 
      the two most prevalent stages in sRPN patients were pT1a (69%) and pT3a (6%). 
      sRRN and sRPN have similar operative and perioperative outcomes. sRPN is a safe 
      and feasible procedure when performed by experienced surgeons. Future studies on 
      large cohorts are essential to better characterize the importance and benefit of 
      salvage partial nephrectomies.
CI  - (c) 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., 
      part of Springer Nature.
FAU - Okhawere, Kennedy E
AU  - Okhawere KE
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Grauer, Ralph
AU  - Grauer R
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Zuluaga, Laura
AU  - Zuluaga L
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Meilika, Kirolos N
AU  - Meilika KN
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Ucpinar, Burak
AU  - Ucpinar B
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Beksac, Alp Tuna
AU  - Beksac AT
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Razdan, Shirin
AU  - Razdan S
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Saini, Indu
AU  - Saini I
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Abramowitz, Chiya
AU  - Abramowitz C
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Abaza, Ronney
AU  - Abaza R
AD  - Department of Urology, OhioHealth Dublin Methodist Hospital, Dublin, OH, USA.
FAU - Eun, Daniel D
AU  - Eun DD
AD  - Department of Urology, Lewis Katz School of Medicine Temple University, 
      Philadelphia, PA, USA.
FAU - Bhandari, Akshay
AU  - Bhandari A
AD  - Division of Urology, Mount Sinai Medical Center, Miami Beach, FL, USA.
FAU - Hemal, Ashok K
AU  - Hemal AK
AD  - Department of Urology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
FAU - Porter, James
AU  - Porter J
AD  - Department of Urology, Swedish Urology, Seattle, WA, USA.
FAU - Stifelman, Michael D
AU  - Stifelman MD
AD  - Department of Urology, Hackensack University Medical Center, Hackensack, NJ, USA.
FAU - Menon, Mani
AU  - Menon M
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA.
FAU - Badani, Ketan K
AU  - Badani KK
AD  - Department of Urology, Icahn School of Medicine at Mount Sinai, 1425 Madison 
      Avenue, 6th Floor, New York City, NY, 10029, USA. ketan.badani@mountsinai.org.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
DEP - 20230316
PL  - England
TA  - J Robot Surg
JT  - Journal of robotic surgery
JID - 101300401
SB  - IM
MH  - Humans
MH  - *Robotic Surgical Procedures/methods
MH  - *Kidney Neoplasms/surgery/pathology
MH  - Treatment Outcome
MH  - Nephrectomy/adverse effects/methods
MH  - Retrospective Studies
MH  - Ischemia
OTO - NOTNLM
OT  - Recurrent renal cancer
OT  - Repeat partial nephrectomy
OT  - Repeat radical nephrectomy
OT  - Robotic surgery
OT  - Salvage nephrectomy
EDAT- 2023/03/18 06:00
MHDA- 2023/07/28 06:42
CRDT- 2023/03/17 09:28
PHST- 2022/08/23 00:00 [received]
PHST- 2023/01/08 00:00 [accepted]
PHST- 2023/07/28 06:42 [medline]
PHST- 2023/03/18 06:00 [pubmed]
PHST- 2023/03/17 09:28 [entrez]
AID - 10.1007/s11701-023-01538-6 [pii]
AID - 10.1007/s11701-023-01538-6 [doi]
PST - ppublish
SO  - J Robot Surg. 2023 Aug;17(4):1579-1585. doi: 10.1007/s11701-023-01538-6. Epub 
      2023 Mar 16.